News

Kaiser Family Foundation releases animated video explaining how ACA will impact Americans

BY Michael Johnsen

MENLO PARK, Calif. — With major parts of the Patient Protection and Affordable Care Act going into effect in 2014, the Kaiser Family Foundation released a new animated video to help people understand the healthcare system changes on the horizon. “The YouToons Get Ready for Obamacare” explains the basic changes in the way Americans will get health coverage and what it will cost starting in 2014, whether it’s through their employer, Medicaid, Medicare or buying insurance on their own with the help of federal tax credits. 

“The reality is that nearly every American will be touched by the Affordable Care Act in ways small and large, and many will face important decisions this fall,” stated Kaiser Family Foundation president Drew Altman. “This cartoon is meant to demystify a complex law and explain what it means for you, whether you support or oppose Obamacare.”

Written and produced by the Foundation and narrated by former ABC News anchor Charlie Gibson, a member of the Foundation’s Board of Trustees, the animation was developed to inform and educate Americans about what will — and what will not — change under the ACA. 

An April 2013, Kaiser Health Tracking Poll found that 42% of Americans were unaware that the ACA is still being implemented, and about half of the public said they did not have enough information about the health reform law to understand how it would impact their own family. 

The open enrollment for health insurance marketplaces starts Oct. 1. 

A Spanish-language version of the video will be released in the future, Kaiser Family reported.

keyboard_arrow_downCOMMENTS

Leave a Reply

R.MURRAY says:
Jul-22-2013 12:37 pm

Must be a liberal company or very naive. This video is over simplified for obvious reasons I reckon. However it does NOT tell the entire story, nor could it I suppose, but the hidden costs are a major problem for large companies, individuals, hospitals, physicians and anyone in the health care arena. This video is good for the less-informed people of this country. Anyone who bothers to read/research the issue knows otherwise. Then again the video could be the companies attempt at a fair analysis. Yall decide reader...

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

CCA Industries posts Q2 results

BY Antoinette Alexander

EAST RUTHERFORD, N.J. — Health and beauty aid manufacturer CCA Industries, whose brands include Plus+White toothpastes and teeth whiteners and Nutra Nail nail care treatments, swung to a loss during the second quarter but expressed optimism for the fourth quarter.

The company reported total revenues for the second quarter ended May 31 of $11.3 million and a net loss of $156,836. For the same period of 2012, the company had revenues of $14.7 million and net income of $302,100. The basic and fully diluted loss per share for second quarter 2013 was 2 cents compared with basic and fully diluted earnings per share of 4 cents for the same period of 2012. 

"The company is still continuing to upgrade its sales and marketing operations. Although the second-quarter results were an improvement from the first quarter, it was not as good as we had planned. Nevertheless, as indicated in my previous shareholders’ letter, I am still confident the company will begin to provide profitable sales in the fourth quarter," stated David Edell, CEO.

The company also announced that its board of directors has approved a dividend of 7 cents per share for the second quarter of fiscal 2013, payable to all shareholders of record as of Aug. 2 and to be paid on Sept. 3.
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Royalty Pharma hires former Morgan Stanley analyst as VP

BY Alaric DeArment

NEW YORK — Royalty Pharma has hired Marshall Urist as VP research and investments, the company said Friday.

Royalty, which invests in royalty interests in drugs, hired Urist from Morgan Stanley, where he worked most recently as executive director and the senior biotechnology analyst.

"We are excited to have Marshall join our team," Royalty founder and CEO Pablo Legorreta said. "He has had a distinguished career on Wall Street, and this experience, coupled with his deep analytical skills, make him an excellent addition to Royalty Pharma."

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?